Clenbuterol, a beta-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients.
about
Effects of inhaled salbutamol in exercising non-asthmatic athletesRegulation of SMN protein stabilityAthletes and doping: effects of drugs on the respiratory systemActivation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditionsEffects of chronic administration of clenbuterol on contractile properties and calcium homeostasis in rat extensor digitorum longus muscle.Sexual dimorphism in the growth response of entire and gonadectomized rats to clenbuterol.Novel approaches to treat muscular dystrophies.Gym and tonic: a profile of 100 male steroid users.Contemporary drug therapy in palliative care: new directions.Therapeutic strategies for the treatment of spinal muscular atrophy.Albuterol aids resistance exercise in reducing unloading-induced ankle extensor strength losses.Effect of clenbuterol on athletic performance.Effects of intermittent weight-bearing and clenbuterol on disuse atrophy of rat hindlimb muscles.Randomized, double-blind, and placebo-controlled trial of clenbuterol in denervated muscle atrophy.Acute clenbuterol overdose resulting in supraventricular tachycardia and atrial fibrillation.Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease.G(s)alpha deficiency in skeletal muscle leads to reduced muscle mass, fiber-type switching, and glucose intolerance without insulin resistance or deficiency.beta(2)-Adrenergic agonist administration and strength training.A descriptive study of adverse events from clenbuterol misuse and abuse for weight loss and bodybuilding.Effects of combined stretching and clenbuterol on disuse atrophy in rat soleus muscle.Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. FSH Consortium.Clenbuterol and formoterol decrease force production in isolated intact mouse skeletal muscle fiber bundles through a beta2-adrenoceptor-independent mechanism.Partial functional recovery after complete spinal cord transection by combined chondroitinase and clenbuterol treatment.Elevated IGF-II mRNA and phosphorylation of 4E-BP1 and p70(S6k) in muscle showing clenbuterol-induced anabolism.Effect of salbutamol, a beta-2-adrenergic agonist, on erythropoietin concentration in healthy males.Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the beta2-adrenergic receptor.Myotoxic effects of clenbuterol in the rat heart and soleus muscle.Beta 2-agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol.Beta 2-agonist administration reverses muscle wasting and improves muscle function in aged rats.Effect of beta2-adrenergic agonist clenbuterol on ischemia/reperfusion injury in isolated rat hearts and cardiomyocyte apoptosis induced by hydrogen peroxide.Phase I/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy.The muscle-hypertrophic effect of clenbuterol is additive to the hypertrophic effect of myostatin suppression.Double disruption of α2A- and α2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype.A pilot trial with clenbuterol in amyotrophic lateral sclerosis
P2860
Q24679011-A2EBB891-D33C-46B7-877D-AA4E1EB52F2FQ28304878-B2B81B26-99E3-4FF7-8743-9BFF5B757E7CQ33753658-2310A385-9454-42E8-A3F3-3A6F6703D7D4Q33804521-D0AEE30A-DED3-4C09-9D98-E6476EF7F370Q33817082-0923F52B-41BC-4250-A920-F260494DA906Q34058198-ED1B099C-BE3A-4B79-8F92-802CBC7E6E87Q34204364-DAAEB707-3545-47BD-B137-DCC11BF16A37Q34265523-C3CAE296-5D7A-4009-9B34-B84A5D5DAEC6Q34280867-4C9406DF-1324-44B2-979A-1BA5D20CBA14Q34296140-A14B7F58-CECF-4088-BA93-4A4D7541000BQ34382903-51344A13-6C5D-4AB2-9A3D-6773D88C2213Q34721901-257EF0DC-6EA6-48D1-9B26-07CAFCB1FC24Q35047104-0EC1ACAC-D880-4940-943F-76793A218B4DQ35687767-803AAECB-E4EE-47D1-A963-332BD9405168Q36548523-584F3A62-0DDA-46B4-A7D2-757935C8E143Q37129351-ACFF44E1-0381-452D-8E2D-4455621C7291Q37162369-C23A84D7-3D7C-43B1-B4ED-C95AB8AC4D05Q37667545-0524F1C2-538D-4647-A8F4-811569B2C965Q38120827-804EC7F8-2CAD-485A-8E34-E8F225B9FA47Q41189517-DD985D7E-4434-4912-9579-623904914726Q41722882-D5586E19-E683-4CDF-9C5C-0C29D80203AAQ42877946-DE5EDC00-2FA5-48BD-A513-541CB7AB4030Q43019751-73B662BB-EFC9-4497-B693-CCB782DFD1CCQ43733879-1F1CA9C3-E39B-47E2-9618-8EDCDBF2F8BBQ43977361-58C9AF85-6400-4B3E-8BC9-F600F0417A94Q43982825-369A47D2-4AA2-44E3-BC5A-5CCF449C9471Q44180856-234A8266-958E-4F6E-86B2-B8A907775DECQ44185897-6DF3CA82-7603-41FD-BA8D-85D1F10DBF01Q44655921-8134D92F-589C-41F2-8FD3-881B754C0FD5Q46577549-831583B7-857D-45B7-9E8A-75DE782C081AQ50248491-E68A4E49-0C8E-43AD-A16B-0097BEEEF5A3Q51481701-FBB8EE80-CD1B-4596-A7D4-9A147EEBFE0FQ51543957-2F2B1B19-8265-4D86-B0DE-F9C7A4BA0637Q58125362-77AF82DE-D7CF-4696-BD85-1B0AD9FC2B6F
P2860
Clenbuterol, a beta-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Clenbuterol, a beta-adrenocept ...... ength in orthopaedic patients.
@en
Clenbuterol, a beta-adrenocept ...... ength in orthopaedic patients.
@nl
type
label
Clenbuterol, a beta-adrenocept ...... ength in orthopaedic patients.
@en
Clenbuterol, a beta-adrenocept ...... ength in orthopaedic patients.
@nl
prefLabel
Clenbuterol, a beta-adrenocept ...... ength in orthopaedic patients.
@en
Clenbuterol, a beta-adrenocept ...... ength in orthopaedic patients.
@nl
P2093
P356
P1433
P1476
Clenbuterol, a beta-adrenocept ...... ength in orthopaedic patients.
@en
P2093
C A Maltin
I K Ritchie
I M Nevison
J S Watson
M I Delday
P H Gibson
P304
P356
10.1042/CS0840651
P407
P577
1993-06-01T00:00:00Z